SCHEMBL4949428

SCHEMBL4949428

C[C@H](O)C(=O)NCCO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28708501 1.00
SCHEMBL49978 1.00
Phosphoric Acid SCHEMBL1399081 0.91 MEN1 (0.56)
SCHEMBL176290 0.91 MEN1 (0.56)
Pentane SCHEMBL7772281 0.89 MEN1 (0.54)
SCHEMBL8533026 0.87 KMT2A (0.67)
SCHEMBL27684618 0.86 MEN1 (0.50)
SCHEMBL1399165 0.86 PTGS1 (0.58)
SCHEMBL146290 0.82
SCHEMBL16130066 0.81 MEN1 (0.74)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130281387-A1 Chemosensory Receptor Ligand-Based Therapies ELCELYX THERAPEUTICS, INC. (US) 2013-10-24 US disclosed
US-20120238540-A1 AMINO-PYRIMIDINE COMPOUNDS AS INHIBITORS OF IKK EPSILON AND/OR TBK1 MYREXIS, INC. (US) 2012-09-20 US disclosed
WO-2012054528-A2 CHEMOSENSORY RECEPTOR LIGAND-BASED THERAPIES ELCELYX THERAPEUTICS, INC. (US) 2012-04-26 WO disclosed